Dose-dependent Effect of an Oral Adsorbent, AST-120, in Patients with Early Chronic Renal Failure

By Yorioka N   Ito T   Masaki T   Ogata S   Asakimori Y   Tanji C   Kyuden Y   Komiya Y   Kumagai J   Taniguchi Y   Kohno N  

The Journal of International Medical Research, Vol. 30, Iss. 5, 2002-09 ,pp. : 467-475

Field House Publishing

Access to resources Recommend Favorite

An Oral Adsorbent, AST-120 Protects Against the Progression of Oxidative Stress by Reducing the Accumulation of Indoxyl Sulfate in the Systemic Circulation in Renal Failure

By Shimoishi Kazuki   Anraku Makoto   Kitamura Kenichiro   Tasaki Yuka   Taguchi Kazuaki   Hashimoto Mitsuru   Fukunaga Eiko   Maruyama Toru   Otagiri Masaki  

Pharmaceutical Research, Vol. 24, Iss. 7, 2007-07 ,pp. : 1283-1289

Springer Publishing Company

Access to resources Recommend Favorite

Long-term oral carvedilol in chronic heart failure

By Di Lenarda Andrea   Sabbadini Gastone   Moretti Michele   Sinagra Gianfranco  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1359-1372

Informa Healthcare

Access to resources Recommend Favorite

The oral adsorbent, AST 120 [Kremezin; Kureha Chemical], has been approved in South Korea

By  

Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Oral valproic acid for epilepsy - long-term experience in therapy and side effects

By Gerstner Thorsten   Bell Nellie   König Stephan  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 285-292

Informa Healthcare

Access to resources Recommend Favorite